Skip to main content
. 2020 Feb 12;24(6):3625–3633. doi: 10.1111/jcmm.15055

Figure 1.

Figure 1

Cisplatin sensitivity and EMT are associated with GPR30 in GC cell lines. A, Western blot analysis of GPR30 in GC cells exposed to cisplatin. B, Viability of AGS, BGC‐823 cells transfected with GPR30 siRNA or negative control siRNA and treated with a series of concentrations of cisplatin for 48 h, measured using the CCK‐8 assay. C, Western blot analysis of E‐cadherin and vimentin in GC cells transfected with GPR30 siRNA or negative control siRNA. D,E, GAPDH was used as the control to quantify the expression of related proteins in AGS, BGC‐823 cells. *P < .05, **P < .01 and ***P < .001